Edesa Biotech (EDSA) Total Current Liabilities (2013 - 2026)
Edesa Biotech (EDSA) reported Total Current Liabilities of $3.91 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 481.3% from $672,674 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Total Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech posted Total Current Liabilities of $1.08 million, down 41.2% from FY2024.
- Total Current Liabilities has a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- By fiscal year, Total Current Liabilities came in at $1.83 million in FY2024 (+0.6%), $1.82 million in FY2023 (-14.9%), $2.14 million in FY2022 (+46.8%) and $1.46 million in FY2021 (-4.7%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Total Current Liabilities since fiscal Q3 2022.
- Year over year, Total Current Liabilities gained in two of the last seven quarters, with growth averaging 35.3%.
- The high point for year-over-year Total Current Liabilities in five years was fiscal Q3 2026 (growth of 481.3%); the low point was fiscal Q3 2023 (a decline of 73.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Dec 31, 2025 | 756,163.00 |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 672,674.00 |
| Mar 31, 2025 | 914,701.00 |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Jun 30, 2022 | 5.66 Mn |
| Mar 31, 2022 | 3.34 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 983,467.00 |
API Access
Edesa Biotech Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();